These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4001865)

  • 1. Successes and failures of intravenous immunoglobulin.
    Atrah HI; Crawford RJ; Gabra GS; Mitchell R
    Scand J Haematol; 1985 Apr; 34(4):345-7. PubMed ID: 4001865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High-dose intravenous immunoglobulins in the treatment of immune blood cytopenia. Mechanisms of action, indications and results].
    Aymard JP; Ferry R; Janot C; Schooneman F; Streiff F
    Ann Med Interne (Paris); 1990; 141(8):689-97. PubMed ID: 2091513
    [No Abstract]   [Full Text] [Related]  

  • 3. More insights into the mechanism(s) of the intravenous immunoglobulin effect in autoimmunity.
    Pollack S
    Isr J Med Sci; 1992 Feb; 28(2):130-2. PubMed ID: 1559797
    [No Abstract]   [Full Text] [Related]  

  • 4. Innovative uses of intravenous immunoglobulins in clinical hematology. Symposium. December 5, 1986, San Francisco, California. Proceedings.
    Am J Med; 1987 Oct; 83(4A):1-56. PubMed ID: 3118702
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical uses of intravenous immunoglobulins.
    Berkman SA; Lee ML; Gale RP
    Semin Hematol; 1988 Apr; 25(2):140-58. PubMed ID: 3291131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin therapy in immunohematological disorders.
    Choudhry VP; Mahapatra M; Kashyap R
    Indian J Pediatr; 1998; 65(5):681-90. PubMed ID: 10773923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use and mechanism of action of intravenous immunoglobulin in the treatment of immune haematologic disease.
    Bussel JB; Hilgartner MW
    Br J Haematol; 1984 Jan; 56(1):1-7. PubMed ID: 6367804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of intravenous immunoglobulin in blood disorders.
    Newland AC
    Blood Rev; 1988 Sep; 2(3):157-67. PubMed ID: 3052661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined effect of intravenous human immunoglobulin (GV-523) and antibiotics in severe infections in the fields of internal medicine and surgery].
    Mashimo K
    Kansenshogaku Zasshi; 1983 Aug; 57(8):724-49. PubMed ID: 6420484
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood platelet transfusion in a refractory state--HLA-matched transfusion and high-dose intravenous immunoglobulin].
    Fujii H; Maekawa T; Saji H; Maruya E
    Rinsho Ketsueki; 1986 Jul; 27(7):1268-73. PubMed ID: 3784008
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cyclic thrombocytopenia treated by high-dose intravenous immunoglobulin with a favorable response].
    Aoki Y; Fujisawa K; Ikegami M; Ishitoya N; Akatsuka J
    Rinsho Ketsueki; 1988 May; 29(5):705-10. PubMed ID: 3216497
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose intravenous immunoglobulin for multiple sclerosis.
    Yan J; Richert JR; Sirdofsky MD
    Lancet; 1990 Sep; 336(8716):692. PubMed ID: 1975879
    [No Abstract]   [Full Text] [Related]  

  • 13. Applications of intravenous immunoglobulin.
    Yap PL
    Malays J Pathol; 1990 Jun; 12(1):1-10. PubMed ID: 2090883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to infectious disease screening and immunization guidelines when treating non-malignant immune-mediated hematologic disorders.
    Malpica-Castillo LE; Palmer S; Zhu A; Deal AM; Chen SL; Moll S
    Am J Hematol; 2020 Mar; 95(3):E72-E75. PubMed ID: 31872481
    [No Abstract]   [Full Text] [Related]  

  • 15. Positive immunohematologic and serologic test results due to high-dose intravenous immune globulin administration.
    Garcia L; Huh YO; Fischer HE; Lichtiger B
    Transfusion; 1987; 27(6):503. PubMed ID: 3318029
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of intravenous normal immunoglobulin in high doses as a possible safer alternative to oral steroids in managing HIV-associated immune thrombocytopenic purpura.
    Ellis M; Flegg P; Alderson D
    J Infect; 1986 Nov; 13(3):312-3. PubMed ID: 3794374
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical use of immunoglobulins].
    Nicodemo AC; Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1992; 47(1):46-52. PubMed ID: 1307403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of intravenous immunoglobulin to affect the recovery of immune function after measles.
    Shieh CC; Hsieh KH
    Pediatr Infect Dis J; 1989 Dec; 8(12):888-91. PubMed ID: 2626291
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of immunoglobulin preparations for intravenous use.
    Barandun S; Isliker H
    Vox Sang; 1986; 51(2):157-60. PubMed ID: 3535252
    [No Abstract]   [Full Text] [Related]  

  • 20. Manipulating the immune system with immune globulin.
    Dwyer JM
    N Engl J Med; 1992 Jan; 326(2):107-16. PubMed ID: 1727218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.